The Food and Drug Administration's approval in 2023 of lecanemab — a novel Alzheimer's therapy shown in clinical trials to…
Read More »tolerated
Susie Wiles, President-elect Trump’s incoming White House chief of staff, said there won’t be any “backbiting” or “drama” tolerated in…
Read More »